Browsing byAuthorIrwig, L

Jump to a point in the index:
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)
2019-01-01Erratum: Prognostic impact of systolic blood pressure variability in people with diabetes (PLoS ONE (2019) 13:4(e0194084)DOI:10.1371/journal.pone.0194084)Bell, KJL; Azizi, L; Nilsson, PM; Hayen, A; Irwig, L; Östgren, CJ; Sundström, J
2018-04-01Prognostic impact of systolic blood pressure variability in people with diabetesBell, KJL; Azizi, L; Nilsson, PM; Hayen, A; Irwig, L; Östgren, CJ; Sundröm, J
2018-01-01Legacy effects of statins on cardiovascular and all-cause mortality: A meta-analysisNayak, A; Hayen, A; Zhu, L; McGeechan, K; Glasziou, P; Irwig, L; Doust, J; Gregory, G; Bell, K
2017-01-17Change in bone mineral density is an indicator of treatment-related antifracture effectBell, KJL; Hayen, A; Glasziou, P; Irwig, L; Bauer, DC
2014-02-01Criteria for monitoring tests were described: Validity, responsiveness, detectability of long-term change, and practicalityBell, KJL; Glasziou, PP; Hayen, A; Irwig, L
2014-01-01Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: Secondary analysis of observational study dataBell, KJL; Beller, E; Sundström, J; McGeechan, K; Hayen, A; Irwig, L; Neal, B; Glasziou, P
2014-01-01General practitioners' use of absolute risk versus individual risk factors in cardiovascular disease prevention: An experimental studyJansen, J; Bonner, C; McKinn, S; Irwig, L; Glasziou, P; Doust, J; Teixeira-Pinto, A; Hayen, A; Turner, R; McCaffery, K
2013-10-07General practitioners' use of different cardiovascular risk assessment strategies: a qualitative studyBonner, C; Jansen, J; McKinn, S; Irwig, L; Doust, J; Glasziou, P; Hayen, A; McCaffery, K
2013-05-04When to remeasure cardiovascular risk in untreated people at low and intermediate risk: Observational studyBell, KJL; Hayen, A; Irwig, L; Takahashi, O; Ohde, S; Glasziou, P
2012-12-01Effects of additional blood pressure and lipid measurements on the prediction of cardiovascular riskBell, K; Hayen, A; McGeechan, K; Neal, B; Irwig, L
2012-01-01The potential value of monitoring bone turnover markers among women on alendronateBell, KJL; Hayen, A; Irwig, L; Hochberg, MC; Ensrud, KE; Cummings, SR; Bauer, DC
2012-01-01Control charts demonstrated limited utility for the monitoring of lung function in asthmaTurner, RM; Hayen, A; MacAskill, P; Irwig, L; Reddel, HK
2011-12-10Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanomaTurner, RM; Bell, KJL; Morton, RL; Hayen, A; Francken, AB; Howard, K; Armstrong, B; Thompson, JF; Irwig, L
2011-01-29Monitoring adherence to drug treatment by using change in cholesterol concentration: Secondary analysis of trial dataBell, KJL; Kirby, A; Hayen, A; Irwig, L; Glasziou, P